Major European pharmaceutical companies are conducting extensive preclinical research to identify and validate new drug targets and biomarkers across various cancer types. This early stage research is crucial to inform clinical development of novel oncology therapies....
Exciting oncology research is underway at several emerging European biopharmaceutical firms. Advances in cancer immunotherapies, antibody-drug conjugates, and combination therapies are highlighted in recent disclosures from these companies targeting both solid tumors...
Cancer remains one of the leading causes of death globally, with an estimated 10 million cancer deaths in 2020 alone. Major European pharmaceutical companies are continuously conducting clinical trials to develop innovative new cancer treatments and improve patient...
So far this year, Amplion has tracked 67 Seed and Series A investments into early-stage biotechs – down from 92 or a 27% decrease during the same period last year. That said, the biotech sector continues to witness rapid advancements, with numerous early-stage...
Amplion Lead Generation and Prospecting: A Guide for Life Science Sales and Marketing Teams In this guide, you’ll learn ways to master: Identifying your ideal accounts Finding new and emerging accounts Learning your key account’s story Connecting with...
Life science commercial teams spend a lot of time trying to find the right customers. Ever wonder why that is? Nah. You know it’s because finding the right contacts—those directly associated with research or drug development programs aligned to your products and...
